.After a few years in biotech, Mike Quigley, Ph.D., is returning to the pharma fold, taking up the b...
.Achilles Rehabs has actually wrecked its technique. The English biotech is stopping work on its own...
.Aligos Therapeutics is actually proclaiming a midstage gain in metabolic-dysfunction associated ste...
.Basilea Pharmaceutica's job building brand-new antifungals has actually received a significant impr...
.Possessing actually scooped up the USA legal rights to Capricor Therapeutics' late-stage Duchenne m...
.After dismissing the decision meeting for Applied Rehabs' metabolic disorder medicine govorestat, t...
.Novo Nordisk is continuing its own press right into genetic medications, accepting to pay NanoVatio...
.Innovent Biologics has actually made the scenario that its checkpoint inhibitor-cytokine combinatio...
.A phase 3 trial of Daiichi Sankyo and Merck & Co.'s HER3-directed antibody-drug conjugate (ADC) ...
.5 months after Rakovina Rehabs rotated towards artificial intelligence, the cancer-focused biotech ...